Helex designs, validates and delivers therapy specific gRNAs using its proprietary genomics data, bioinformatics and intelligent data-driven platform to companies advancing CRISPR based genome editing therapeutics. Helex is a partner from lab to commercialization, ultimately helping therapeutic companies fasten their time to market.
Location: India
Employees: 1-10
Total raised: $3.5M
Founded date: 2021
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.10.2025 | Seed | $3.5M | Pi Venture... |
Mentions in press and media 8
| Date | Title | Description |
| 01.11.2025 | Helex Secures $3.5M to Revolutionize Kidney Disease Gene Therapy | Helex, a pioneering biotech firm, secured $3.5 million in seed funding. This investment propels gene therapies for chronic kidney diseases. The company targets Autosomal Dominant Polycystic Kidney Disease (ADPKD). Its innovative platform co... |
| 31.10.2025 | VoidZero, SalarySe, Helex, others net early-stage funding | Helex's co-founders Poulami Chaudhuri, Anirudh Nishtala and Rohini Kalvakuntla Developer tools provider VoidZero, fintech platform SalarySe, biotech startup Helex and several other companies have secured funding in various early-stage round... |
| 31.10.2025 | Helex, Beyond Renewables & Recycling, and Exiles Interactives Raise Early-Stage Funding The below brands have announced their latest funding rounds. | Therapeutics Startup Helex Secures USD 3.5 Mn to Develop Targeted Kidney Treatments Helex, a therapeutics startup focused on genetic kidney diseases, has raised USD 3.5 million in a seed funding round led by pi Ventures, with participation... |
| 30.10.2025 | Helex Raises $3.5M in Seed Funding | Helex, a NYC-based therapeutics company developing a new class of targeted medicines for genetic kidney diseases, raised $3.5m in Seed funding. The round was led by pi Ventures, with participation from Bluehill Capital, SOSV, and a global s... |
| 16.05.2023 | The 2023 Cartier Women’s Initiative Awards $100,000 To 11 Entrepreneurs | The 2023 Cartier Women’s Initiative Awards Ceremony in ParisFloris Heuer Makmende Media |
| 01.10.2021 | Here’s all 10 companies from IndieBio’s latest New York cohort | Most big accelerators tend to dedicate some of their resources to dauntingly hard science problems and the companies taking them on… but for SOSV’s IndieBio, it’s the primary focus. Last time we checked in with IndieBio, their companies wer... |
| - | Biotech startup Helex raises $3.5M to advance gene therapies for kidney diseases | Biotechnology startup Helex on Thursday raised $3.5 million in a funding round led by pi Ventures, with participation from Bluehill Capital, SOSV, and a group of global investors, to advance the development of its targeted gene therapies fo... |
| - | Helex | “Revolutionizing genomic medicines. Inspired by patients, directed by nature’s intelligence.” |